Apoptosis induced by nonspecific effects of siRNA in human umbilical vein endothelial cell

Research Article
First Online:
Received:
Revised:
Accepted:
  • 176 Downloads

Abstract

RNA interference (RNAi) is a powerful tool used to produce post-translational gene silencing in a sequence-dependent manner. However, sequence-independent activation of interferon systems induced by double-stranded RNA can interfere with the data interpretation of RNAi experiments. In this study, we observed cytokine activation and cytotoxicity caused by small interfering RNA (siRNA) in human umbilical vein endothelial cells (HUVECs). Transfection with different sequences of siRNAs (21-nucleotides) induced apoptosis in HUVECs within 24 hours, in a dose-dependent and sequence-independent manner. These effects could not be achieved by the application of transfection agents nor by siRNA only. In HUVECs, the expression of toll-like receptor 3 (TLR3), a receptor for double-stranded RNA, was significantly increased by the transfection with siRNAs regardless of their sequences. The expressions of interleukin 6, interleukin 8, and interferon-β were also up-regulated by siRNA transfection. The activation of RNA-dependent protein kinase (PKR) peaked within 30 min and slowly decreased 4 hours after transfection with siRNA, which was followed by the phosphorylation of eukaryotic initiation factor 2α(eIF2α). These studies suggest that transfection with double-stranded oligonucleotides in HUVECs shows sequence-independent apoptotic effects associated with the upregulation of TLR3 and cytokines, which should be considered when designing experiments using RNAi.

Keywords

Small interfering RNA RNA-dependent protein kinase Human umbilical endothelial cell Interferon Apoptosis 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811 (1998).PubMedCrossRefGoogle Scholar
  2. 2.
    Sharp, P. A. RNA interference-2001. Genes Dev. 15: 485–490 (2001).PubMedCrossRefGoogle Scholar
  3. 3.
    Bernstein, E. et al. Dicer is essential for mouse development. Nat. Genet. 35, 215–217 (2003).PubMedCrossRefGoogle Scholar
  4. 4.
    Hannon, G. J. RNA interference. Nature 418, 244–251 (2002).PubMedCrossRefGoogle Scholar
  5. 5.
    Persengiev, S. P., Zhu, X. & Green, M. R. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12–18 (2004).PubMedCrossRefGoogle Scholar
  6. 6.
    Alexopoulou, L., Holt, A. C. Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732–738 (2001).PubMedCrossRefGoogle Scholar
  7. 7.
    Yamamoto, M. et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668–6672 (2002).PubMedGoogle Scholar
  8. 8.
    Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).PubMedCrossRefGoogle Scholar
  9. 9.
    Jacque, J. M., Triques, K. & Stevenson, M. Modulation of HIV-1 replication by RNA interference. Nature 418, 435–438 (2002).PubMedCrossRefGoogle Scholar
  10. 10.
    Kim, D. H. et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22, 321–325 (2004).PubMedCrossRefGoogle Scholar
  11. 11.
    Sledz, C. A. et al. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834–839 (2003).PubMedCrossRefGoogle Scholar
  12. 12.
    Kariko, K., Bhuyan, P., Capodici, J. & Weissman, D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J. Immunol. 172, 6545–6549 (2004).PubMedGoogle Scholar
  13. 13.
    Faure, E. et al. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275, 11058–11063 (2000).PubMedCrossRefGoogle Scholar
  14. 14.
    de Kleijn, D. & Pasterkamp, G. Toll-like receptors in cardiovascular diseases. Cardiovasc. Res. 60, 58–67 (2003).PubMedCrossRefGoogle Scholar
  15. 15.
    Donze, O. & Picard, D. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res. 30, e46 (2002).PubMedCrossRefGoogle Scholar
  16. 16.
    Oshiumi, H. et al. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferonbeta induction. Nat. Immunol. 4, 161–167 (2003).PubMedCrossRefGoogle Scholar
  17. 17.
    Cook, D. N., Pisetsky, D. S. & Schwartz, D. A. Tolllike receptors in the pathogenesis of human disease. Nat. Immunol. 5, 975–979 (2004).PubMedCrossRefGoogle Scholar
  18. 18.
    Matsumoto, M. et al. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293, 1364–1369 (2002).PubMedCrossRefGoogle Scholar
  19. 19.
    Wang, Q. & Carmichael, G. G. Effects of length and location on the cellular response to double-stranded RNA. Microbiol. Mol. Biol. Rev. 68, 432–452 (2004).PubMedCrossRefGoogle Scholar
  20. 20.
    Bridge, A. J. et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263–264 (2003).PubMedCrossRefGoogle Scholar
  21. 21.
    McAllister, C. S. & Samuel, C. E. The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors. J. Biol. Chem. 284, 1644–1651 (2009).PubMedCrossRefGoogle Scholar
  22. 22.
    Reynolds, A. et al. Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 12, 988–993 (2006).PubMedCrossRefGoogle Scholar
  23. 23.
    Siolas, D. et al. Synthetic shRNAs as potent RNAi triggers. Nat. Biotechnol. 23, 227–231 (2005).PubMedCrossRefGoogle Scholar
  24. 24.
    Samuel, C. E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778–809, table of contents (2001).PubMedCrossRefGoogle Scholar
  25. 25.
    Bevilacqua, P. C., George, C. X., Samuel, C. E. & Cech, T. R. Binding of the protein kinase PKR to RNAs with secondary structure defects: role of the tandem A-G mismatch and noncontiguous helixes. Biochemistry 37, 6303–6316 (1998).PubMedCrossRefGoogle Scholar
  26. 26.
    Zhang, P. & Samuel, C. E. Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J. Virol. 81, 8192–8200 (2007).PubMedCrossRefGoogle Scholar
  27. 27.
    Gil, J. & Esteban, M. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5, 107–114 (2000).PubMedCrossRefGoogle Scholar
  28. 28.
    Tschaharganeh, D. et al. Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference. Pathol. Oncol. Res. 13, 84–90 (2007).PubMedCrossRefGoogle Scholar

Copyright information

© Korean Society of Environmental Risk Assessment and Health Science and Springer 2012

Authors and Affiliations

  1. 1.Department of Biochemistry, Wonju College of MedicineYonsei UniversityWonjuKorea
  2. 2.Department of Microbiology, Wonju College of MedicineYonsei UniversityWonjuKorea
  3. 3.Department of Biomedical Engineering, College of Health ScienceYonsei UniversityWonjuKorea
  4. 4.Institute of Lifestyle Medicine, Wonju College of MedicineYonsei UniversityWonjuKorea
  5. 5.Department of Preventive Medicine, Wonju College of MedicineYonsei UniversityWonjuKorea
  6. 6.Department of Physiology, Wonju College of MedicineYonsei UniversityWonjuKorea
  7. 7.Uirim Biotech Co. Ltd.JeachenKorea

Personalised recommendations